Pre-Seed Funding for Startups: Evidence, Instruments, and Process

Pre-seed funding is early outside capital used to reduce the first major company risks: problem, customer, product, technical feasibility, regulatory path, or initial go-to-market. “Pre-seed” is a market label, not a legal category, and it has no universal round size, valuation, revenue requirement, or instrument.

This guide is U.S.-oriented general education as of July 2026. Investor norms and securities, company, tax, employment, and disclosure laws vary by jurisdiction and facts. Work with qualified counsel and tax professionals before offering securities or accepting money.

Pre-seed vs seed

The distinction is better understood through evidence and use of funds than copied monetary ranges.

The boundary varies. The pre-seed vs seed guide compares the stages in more depth. If your evidence and milestone are seed-like, use the seed fundraising process.

Current market context without fake benchmarks

Carta's State of Pre-Seed: Q1 2026 analyzes U.S.-based pre-seed activity on its platform, particularly SAFEs and convertible notes. It reports a market that stabilized near recent-quarter levels and shows meaningful sector differences, including a large AI share of dollars.

Use that report for context, not prescription:

• Carta data is not every startup or geography.
• Sector concentration can distort broad comparisons.
• A median does not determine the right amount or cap for one company.
• Instrument terms interact with future rounds, ownership, tax, and law.

If a number does not connect to your milestone, cap table, and investor process, it is not a fundraising strategy.

Decide what the pre-seed round must accomplish

Write the current state and next evidence:

Today we know [supported evidence]. We still do not know [major risk]. We will use capital to run [work] and decide [specific milestone] within [modeled period].

Examples of decision-relevant milestones:

• Complete a safety-appropriate technical POC and a target-customer prototype test.
• Convert manual pilots into repeated use for one narrow customer segment.
• Establish the regulatory pathway and complete an agreed development gate.
• Show that qualified buyers will enter a paid implementation process.

Avoid “build product, hire team, and grow.” Those are activities. The milestone should explain which uncertainty becomes smaller.

Build a pre-seed evidence packet

Customer and problem

• Target user, buyer, and trigger.
• Recent observed workflows.
• Current alternatives and consequences.
• Contradictory evidence and non-fit segments.

Product and feasibility

• Prototype, POC, concierge delivery, or MVP and the question each answered.
• Value-event definition.
• Customer completion or commitment.
• Important technical, security, safety, or regulatory limits.

Commercial

• Paid pilots, contracts, preorders, or other exact commitments, if any.
• Acquisition source for each qualified conversation.
• Pricing and delivery assumptions.
• Repeat use or the date when customers become eligible to repeat.

Team and company

• Why the founders have relevant insight, skill, or access.
• Founder roles, ownership, vesting, and time commitment.
• Entity, intellectual property, cap table, and material agreements.
• Gaps the milestone requires the team to fill.

Use the pre-seed metrics guide to define model-specific evidence without universal pass marks.

Model the use of funds

Build a monthly model with a base and downside case.

Include transaction costs, payroll and employer costs, contractors, product and infrastructure, insurance, tax, and contingency assumptions.

Simple runway = unrestricted operating cash ÷ expected monthly net cash outflow

When hiring and spending change over time, use the actual monthly schedule rather than one average. Model what happens if fundraising closes late, product evidence is weaker, or the next round is unavailable.

Understand common instruments

The instrument should be chosen with counsel based on company, investors, jurisdiction, ownership plan, tax, and future financing—not convenience alone.

Labels and documents differ by jurisdiction and version. A “standard” template still creates company-specific consequences.

The SEC lists common startup securities, including stock, LLC interests, notes, and SAFEs. Read the actual document with counsel and model dilution across plausible future rounds.

Find investors who fit the thesis

Create an evidence-backed target list:

• Stage and typical initial investment.
• Sector and business-model focus.
• Geography and entity requirements.
• Relevant portfolio and possible conflicts.
• Decision makers and process.
• Ownership and follow-on strategy.
• Verified recent activity.
• Route: warm introduction, founder referral, program, or relevant direct message.

Pre-seed investors can include angels, micro-funds, accelerator funds, specialist funds, strategic investors, and some larger funds. The label does not tell you whether the investor's economics, attention, governance, or expectations fit.

Ask portfolio founders about decision speed, support, follow-on behavior, governance, and difficult moments—not only the investor's brand.

Tell an evidence-backed pre-seed story

The deck or memo should answer:

1. Which customer experiences what problem after which trigger?
2. What does the customer do today?
3. What is the product's narrow wedge?
4. What have customers, users, or technical tests actually shown?
5. Why is the team suited to learn faster here?
6. What market can the wedge expand into, and what evidence supports the path?
7. What is the business model hypothesis?
8. Which milestone will the round finance?
9. What are the material risks?

Separate observed facts, customer reports, commitments, and assumptions. A waitlist is not revenue; a prototype task is not retention; a non-binding letter is not a paid contract.

Run a focused process

Use a simple pipeline: researched, contacted, first meeting, decision meeting, diligence, terms, closed or passed.

For every investor, record:

• Fit reason.
• Contact route.
• Last interaction.
• Investor question or concern.
• Requested evidence.
• Next action, owner, and date.
• Decision reason.

Do not manufacture scarcity or claim commitments that do not exist. A clean process creates momentum through preparation and comparable conversations.

Prepare for diligence

Even an early company should organize:

• Formation and governing documents.
• Founder ownership, vesting, IP assignments, and prior promises.
• Current cap table and security documents.
• Financial records, bank information, forecast, and tax status.
• Material customer, vendor, employment, and contractor agreements.
• Product metrics with definitions and source notes.
• Privacy, security, insurance, regulatory, and dispute records.

Provide access proportionally and protect personal, customer, and confidential information. The startup due-diligence guide covers a fuller data room.

U.S. securities-law caution

The SEC explains that every offer and sale of securities by a private company must be registered or qualify for an exemption, even when only one person or friends and family are involved. Communications before and during a raise can matter. Federal exemptions also have different conditions, and state securities laws may apply.

Do not rely on a blog, accelerator template, or investor assurance to determine offering compliance. Engage securities counsel before contacting investors about specific terms or accepting funds. Non-U.S. founders and cross-border raises require advice in every relevant jurisdiction.

Pre-seed mistakes to avoid

Copying a round-size or valuation range

Market reports are context. The financing should follow milestone cost, ownership consequences, demand, and investor fit.

Raising before ownership and IP are clear

Informal equity promises, unassigned code, or founder disputes become harder under diligence.

Calling every positive signal traction

Label the evidence precisely and explain its limits.

Taking the first available money

Review instrument, ownership, governance, reputation, conflicts, information rights, and follow-on implications with advisers.

Spending against the next round

The next financing may take longer or never occur. Maintain a downside plan and release spending against evidence gates.

Pre-seed capital is useful when it finances a clearly named reduction in risk. Know what has been proved, choose the next evidence, model the work and dilution, run a targeted investor process, and treat the transaction with the legal and financial care it requires.